As First Analysis approaches its 40th year of using integrative research to uncover and leverage the best opportunities in emerging high-growth segments in technology and healthcare, it is enhancing its research model and increasing its commitment to publishing research on cutting-edge trends in technology and healthcare.

First Analysis Vice President Joseph Munda’s latest white paper explores the dynamic and rapidly evolving array of digital technology solutions related to drug commercialization. Munda highlights numerous promising opportunities in this burgeoning emerging sector. His work builds on his broad involvement in medical and pharmaceutical technology as well as his 2018 white paper, “eClinical Solutions: Streamlining the introduction of new drugs and medical technology.”

Chicago-based First Analysis Securities Corporation announced Andrew Walsh has joined the firm as a Managing Director. This move expands First Analysis’s investment banking practice and its commitment to advising premier companies in the firm’s healthcare sector.

Terry Kiwala and Logan Bender have joined Chicago-based First Analysis’s venture capital investment and research team.

First Analysis analysts once again ranked among the top performers in their sectors in the Thomson Reuters Analyst Awards for the United States. First Analysis’s Corey Greendale was recognized in multiple categories and for the second year in a row.

First Analysis analysts once again ranked among top performers in their sectors in the Thomson Reuters Analyst Awards for the United States. First Analysis’s Corey Greendale was named No. 1 stock picker for the commercial services & supplies sector.